The Vanguard View - September 2022
Volume IX
September 2022
What's New in the Lab Industry Today?
Economic Uncertainty's Impact on Mergers and Acquisitions in Today's Lab
Since the beginning of 2022, financial markets have come under tremendous pressure as a result of uncertainty introduced by inflation concerns. This economic uncertainty has a direct impact on mergers and acquisitions activity across the economic landscape, and the laboratory industry has been no exception.
Yet Another Curveball in the COVID Mutation Nightmare
When the pharmaceutical industry scrambled to develop the first COVID vaccines back in 2020, it made sense that developers focused on the part of the virus that allows it to grab onto and infect our cells: the spike proteins. But other parts of the virus are changing too. Now, for the first time, a team of scientists has scrutinized these changes - and voiced a warning.
Fauci Warns of a Bad Flu Season Brewing as He Nears Office
President Joe Biden's medical advisor Anthony Fauci warned that the US should be prepared for "pretty bad flu season" coupled with continued COVID-19 cases this winter when he'll be stepping down from his post as the nation's top infectious disease official.
50% of Executives Plan Layoffs as Healthcare Looks to Rehire
A new survey of US executives across numerous sectors finds contradictory sentiments on talent and labor management, with half of respondents indicating they have plans to reduce headcount as more than one-third see talent acquisition and retention as a serious business risk.
Contact Us:
(973) 756 - 5080